Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04182776 · ClinicalTrials.gov registry record

Fragility Fractures of the Pelvis (FFP)

A clinical trial of Pelvic Fracture, sponsored by AO Innovation Translation Center.

Recruiting
Registry status
420
Enrollment target
10
Study locations

NCT04182776 is a study of Pelvic Fracture that is actively recruiting participants, run by AO Innovation Translation Center. The registered enrollment target is 420 participants. The trial reports 10 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04182776, a study of Pelvic Fracture, is actively recruiting participants, sponsored by AO Innovation Translation Center.

RECRUITING
Registry status
420 participants
Enrollment target
10
Study locations

Study Summary

Prospective data will be collected in approximately 420 patients, above the age of 65, suffering from an FFP type fracture equal to or higher than type II, according to Rommens and Hofmann. Patients will be followed up according to the standard (routine) for up to 1 year after the treatment. Data collection will include underlying disease, treatment details, functional and patient reported outcomes (PRO)s, radiological outcomes, and anticipated or procedure-related adverse events (i.e. complications).

Conditions Studied

Study Locations (10)

Other

  • The Ottawa Hospital - Civic Campus - Ottawa
  • University Medical Center Hamburg Eppendorf - Hamburg
  • University Hospital Leipzig - Leipzig
  • University Medical Center Johannes Gutenberg-University - Mainz
  • Queen Mary Hospital - Hong Kong
  • Okayama medical hospital - Okayama
  • University Medical Center Groningen - Groningen
  • Radboud University Medical Center - Nijmegen
  • Cantonal Hospital Lucerne - Lucerne

Missouri

  • University of Missouri - Columbia

Trial Details

FieldValue
Enrollment Target 420 participants
Start Date 2022-03-01
Est. Completion 2026-06

Sponsor

AO Innovation Translation Center

18 total trials

What the Registry Record Tells You About NCT04182776

The ClinicalTrials.gov registry entry for NCT04182776 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 420 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is AO Innovation Translation Center, which has 18 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Pelvic Fracture appearing as the primary indexed condition, and to 0 interventions.

NCT04182776 reports 10 study locations spanning 2 distinct geographic areas - top geographies include Other, Missouri.

Frequently Asked Questions

What is clinical trial NCT04182776 about?

NCT04182776 is a clinical study titled "Fragility Fractures of the Pelvis (FFP)". Prospective data will be collected in approximately 420 patients, above the age of 65, suffering from an FFP type fracture equal to or higher than type II, according to Rommens and Hofmann. Patients will be followed up according to the standard (routine) for up to 1 year after the treatment. Data c...

What is the current status of trial NCT04182776?

This trial is currently recruiting. The enrollment target is 420 participants. The study started on 2022-03-01. Estimated completion is 2026-06.

What conditions does trial NCT04182776 study?

This clinical trial studies the following conditions: Pelvic Fracture.

Who is sponsoring clinical trial NCT04182776?

This trial is sponsored by AO Innovation Translation Center, which has 18 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04182776 being conducted?

This trial has 10 study locations across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pelvic Fracture

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.